These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 6142712)

  • 21. Potentiation by guanine nucleosides of the growth-inhibitory effects of adenosine analogs on L1210 and sarcoma 180 cells in culture.
    Grindey GB; Lowe JK; Divekar AY; Hakala MT
    Cancer Res; 1976 Feb; 36(2 Pt 1):379-83. PubMed ID: 944090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines.
    Singh G; Luna MK; Ardalan B
    Cancer Chemother Pharmacol; 1988; 22(3):191-6. PubMed ID: 2900700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
    Lowy BA; Williams MK
    Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis.
    Beardsley GP; Moroson BA; Taylor EC; Moran RG
    J Biol Chem; 1989 Jan; 264(1):328-33. PubMed ID: 2909524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
    Fukui M; Inaba M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Mar; 42(3):1098-102. PubMed ID: 6120758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):64-70. PubMed ID: 14342250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purine salvage in Schistosoma mansoni schistosomules.
    Dovey HF; McKerrow JH; Wang CC
    Mol Biochem Parasitol; 1984 Apr; 11():157-67. PubMed ID: 6431283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P).
    Moore EC; Hurlbert RB; Boss GR; Massia SP
    Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INHIBITION BY 6-MERCAPTOPURINE OF PURINE PHOSPHORIBOSYLTRANSFERASES FROM EHRLICH ASCITES-TUMOUR CELLS THAT ARE RESISTANT TO THE DRUG.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):71-4. PubMed ID: 14342251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein.
    Munagala NR; Wang CC
    Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual control of the gua operon of Escherichia coli K12 by adenine and guanine nucleotides.
    Mehra RK; Drabble WT
    J Gen Microbiol; 1981 Mar; 123(1):27-37. PubMed ID: 6119351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo synthesis of purine nucleotides in human blood platelets.
    Jerushalmy Z; Patya M; Boer P; Sperling O
    Haemostasis; 1980; 9(1):20-7. PubMed ID: 7351313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
    Ahmed N; Weidemann MJ
    Leuk Res; 1995 Apr; 19(4):263-73. PubMed ID: 7538618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.
    BROCKMAN RW; CHUMLEY S
    Biochim Biophys Acta; 1965 Mar; 95():365-79. PubMed ID: 14342531
    [No Abstract]   [Full Text] [Related]  

  • 36. Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA).
    Balzarini J; Hatse S; Naesens L; De Clercq E
    Biochim Biophys Acta; 1998 Mar; 1402(1):29-38. PubMed ID: 9551083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of guanine and guanine nucleotides in primary rat neuronal cultures.
    Brosh S; Sperling O; Dantziger E; Sidi Y
    J Neurochem; 1992 Apr; 58(4):1485-90. PubMed ID: 1312576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical basis of the prevention of 6-thiopurine toxicity by the nucleobases, hypoxanthine and adenine.
    Hashimoto H; Kubota M; Shimizu T; Takimoto T; Kitoh T; Akiyama Y; Mikawa H
    Leuk Res; 1990; 14(11-12):1061-6. PubMed ID: 2280604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast growth factor-dependent metabolism of hypoxanthine via the salvage pathway for purine synthesis in porcine aortic endothelial cells.
    Hirai S; Hayashi Y; Koizumi T; Nakanishi N; Fukui T; Ichikawa A
    Biochem Pharmacol; 1993 Apr; 45(8):1695-701. PubMed ID: 7683470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purine salvage networks in Giardia lamblia.
    Wang CC; Aldritt S
    J Exp Med; 1983 Nov; 158(5):1703-12. PubMed ID: 6605408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.